Antidepressants: Influence on cancer and immunity?

Life Sciences

Volumn 92, Issue 10, 2013, Pages 525-532

  Frick, Luciana Romina ^a   Rapanelli, Maximiliano ^a,b  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Apoptosis; Cancer; Cytokines; Cytotoxicity; Fluoxetine; Immunity; Tumor proliferation

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CLORGYLINE; CONCANAVALIN A; DESIPRAMINE; DIMETHYLBENZ[A]ANTHRACENE; DOXORUBICIN; FLUOXETINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

APOPTOSIS; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RESISTANCE; CELL CYCLE REGULATION; COLORECTAL CARCINOMA; DISEASE ASSOCIATION; DRUG EFFECT; FIBROSARCOMA; HUMAN; IMMUNITY; IMMUNOMODULATION; MELANOMA; METASTASIS; MULTIDRUG RESISTANCE; NEOPLASM; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; REVIEW; TUMOR IMMUNITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; APOPTOSIS; CELL CYCLE; HUMANS; IMMUNITY, CELLULAR; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NITROSATION; OXIDATION-REDUCTION; RISK FACTORS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84875464200     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.01.020     Document Type: Review

References (118)

1. M. Abdul, C.J. Logothetis, and N.M. Hoosein Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines J Urol 154 1995 247 250
2. B.H. Amit, I. Gil-Ad, M. Taler, M. Bar, A. Zolokov, and A. Weizman Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro Eur Neuropsychopharmacol 19 2009 726 734
3. M. Argov, R. Kashi, D. Peer, and R. Margalit Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen Cancer Lett 274 2009 118 125
4. H. Arimochi, and K. Morita Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells Eur J Pharmacol 541 2006 17 23
5. H. Arimochi, and K. Morita Desipramine induces apoptotic cell death through nonmitochondrial and mitochondrial pathways in different types of human colon carcinoma cells Pharmacology 81 2008 164 172
6. J.E. Ashbury, L.E. Lévesque, P.A. Beck, and K.J. Aronson A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency BMC Med 8 2010 90
7. S. Bahl, M. Cotterchio, N. Kreiger, and N. Klar Antidepressant medication use and non-Hodgkin's lymphoma risk: no association Am J Epidemiol 160 2004 566 575
8. R.A. Bendele, E.R. Adams, W.P. Hoffman, C.L. Gries, and D.M. Morton Carcinogenicity studies of fluoxetine hydrochloride in rats and mice Cancer Res 52 1992 6931 6935
9. L.S. Branco-de-Almeida, M. Kajiya, C.R. Cardoso, M.J. Silva, K. Ohta, and P.L. Rosalen Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes FEMS Immunol Med Microbiol 62 2011 283 294
10. L.J. Brandes, R.J. Arron, R.P. Bogdanovic, J. Tong, C.L. Zaborniak, and G.R. Hogg Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses Cancer Res 52 1992 3796 3800
11. M.J. Brunda, L. Luistro, R.R. Warrier, R.B. Wright, B.R. Hubbard, and M. Murphy Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 178 1993 1223 1230
12. S.R. Campelo, M.B. da Silva, J.L. Vieira, J.P. da Silva, and C.G. Salgado Effects of immunomodulatory drugs on TNF-α and IL-12 production by purified epidermal Langerhans cells and peritoneal macrophages BMC Res Notes 4 2011 24
13. H.C. Chang, C.C. Huang, C.J. Huang, J.S. Cheng, S.I. Liu, and J.Y. Tsai Desipramine-induced apoptosis in human PC3 prostate cancer cells: activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2 +]i elevation Toxicology 250 2008 9 14
14. C. Chien, C.I. Li, S.R. Heckbert, K.E. Malone, D.M. Boudreau, and J.R. Daling Antidepressant use and breast cancer risk Breast Cancer Res Treat 95 2006 131 140
15. C.T. Chou, S. He, and C.R. Jan Paroxetine-induced apoptosis in human osteosarcoma cells: activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2 +]i elevation Toxicol Appl Pharmacol 218 2007 265 273
16. J. Chubak, D.S. Buist, D.M. Boudreau, M.A. Rossing, T. Lumley, and N.S. Weiss Breast cancer recurrence risk in relation to antidepressant use after diagnosis Breast Cancer Res Treat 112 2008 123 132
17. J. Chubak, D.M. Boudreau, S.J. Rulyak, and M.T. Mandelson Colorectal cancer risk in relation to antidepressant medication use Int J Cancer 128 2011 227 232
18. S.M. Cloonan, and D.C. Williams The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma Int J Cancer 128 2011 1712 1723
19. S.M. Cloonan, A. Drozgowska, D. Fayne, and D.C. Williams The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters Leuk Lymphoma 51 2010 523 539
20. P.F. Coogan, L. Rosenberg, J.R. Palmer, B.L. Strom, P.D. Stolley, and A.G. Zauber Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States) Cancer Causes Control 11 2000 839 845
21. P.F. Coogan, J.R. Palmer, B.L. Strom, and L. Rosenberg Use of selective serotonin reuptake inhibitors and the risk of breast cancer Am J Epidemiol 162 2005 835 838
22. P.F. Coogan, B.L. Strom, and L. Rosenberg SSRI use and breast cancer risk by hormone receptor status Breast Cancer Res Treat 109 2008 527 531
23. P.F. Coogan, B.L. Strom, and L. Rosenberg Antidepressant use and colorectal cancer risk Pharmacoepidemiol Drug Saf 18 2009 1111 1114
24. M.D. Cordero, J.A. Sánchez-Alcázar, M.R. Bautista-Ferrufino, M.I. Carmona-López, M. Illanes, and M.J. Ríos Acute oxidant damage promoted on cancer cells by amitriptyline in comparison with some common chemotherapeutic drugs Anticancer Drugs 21 2010 932 944
25. L. Cosgrove, L. Shi, D.E. Creasey, M. Anaya-McKivergan, J.A. Myers, and K.F. Huybrechts Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry PLoS One 6 2011 e18210
26. M. Cotterchio, N. Kreiger, G. Darlington, and A. Steingart Antidepressant medication use and breast cancer risk Am J Epidemiol 151 2000 951 957
27. S.O. Dalton, C. Johansen, L. Mellemkjaer, H.T. Sørensen, J.K. McLaughlin, and J. Olsen Antidepressant medications and risk for cancer Epidemiology 11 2000 171 176
28. S.O. Dalton, A.H. Poulsen, M. Nørgaard, J.K. McLaughlin, C. Johansen, and S. Friis Tricyclic antidepressants and non-Hodgkin lymphoma Epidemiology 19 2008 546 549
29. M. Diamond, J.P. Kelly, and T.J. Connor Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade Eur Neuropsychopharmacol 16 2006 481 490
30. S. Dublin, M.A. Rossing, S.R. Heckbert, B.A. Goff, and N.S. Weiss Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications Cancer Causes Control 13 2002 35 45
31. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330
32. V.A. Edgar, A.M. Genaro, G. Cremaschi, and L. Sterin-Borda Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilisation Cell Signal 10 1998 721 726
33. V.A. Edgar, L. Sterin-Borda, G.A. Cremaschi, and A.M. Genaro Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation Eur J Pharmacol 372 1999 65 73
34. J.N. Eisen, J. Irwin, J. Quay, and S. Livnat The effect of antidepressants on immune function in mice Biol Psychiatry 26 1989 805 817
35. C.K. Fang, H.W. Chen, I.T. Chiang, C.C. Chen, J.F. Liao, and T.P. Su Mirtazapine inhibits tumor growth via immune response and serotonergic system PLoS One 7 2012 e38886
36. F. Fazzino, M. Urbina, N. Cedeño, and L. Lima Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4 + and CD8 + subpopulations and interleukins 2 and 4 Int Immunopharmacol 9 2009 463 467
37. V. Flamand, H. Zhao, and D.M. Peehl Targeting monoamine oxidase A in advanced prostate cancer J Cancer Res Clin Oncol 136 2010 1761 1771
38. M.G. Frank, S.E. Hendricks, D.R. Johnson, J.L. Wieseler, and W.J. Burke Antidepressants augment natural killer cell activity: in vivo and in vitro Neuropsychobiology 39 1999 18 24
39. L.R. Frick, M.L. Palumbo, M.P. Zappia, M.A. Brocco, G.A. Cremaschi, and A.M. Genaro Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms Biochem Pharmacol 75 2008 1817 1826
40. L.R. Frick, M. Rapanelli, G.A. Cremaschi, and A.M. Genaro Fluoxetine directly counteracts the adverse effects of chronic stress on T cell immunity by compensatory and specific mechanisms Brain Behav Immun 23 2009 36 40
41. L.R. Frick, M. Rapanelli, M.L. Arcos, G.A. Cremaschi, and A.M. Genaro Oral administration of fluoxetine alters the proliferation/apoptosis balance of lymphoma cells and up-regulates T cell immunity in tumor-bearing mice Eur J Pharmacol 659 2011 265 272
42. A.M. Genaro, V.A. Edgar, and L. Sterin-Borda Differential effects of fluoxetine on murine B-cell proliferation depending on the biochemical pathways triggered by distinct mitogens Biochem Pharmacol 60 2000 1279 1283
43. I. Gil-Ad, A. Zolokov, L. Lomnitski, M. Taler, M. Bar, and D. Luria Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice Int J Oncol 33 2008 277 286
44. A. González-Pérez, and L.A. García Rodríguez Breast cancer risk among users of antidepressant medications Epidemiology 16 2005 101 105
45. J. Gordon, and N.M. Barnes Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol 24 8 2003 438 443 [Aug]
46. B.L. Harlow, and D.W. Cramer Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies Cancer Causes Control 6 1995 130 134
47. B.L. Harlow, D.W. Cramer, J.A. Baron, L. Titus-Ernstoff, and E.R. Greenberg Psychotropic medication use and risk of epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 7 1998 697 702
48. J. Haukka, R. Sankila, T. Klaukka, J. Lonnqvist, L. Niskanen, and A. Tanskanen Incidence of cancer and antidepressant medication: record linkage study Int J Cancer 126 2010 285 296
49. H. Iishi, M. Tatsuta, M. Baba, and H. Taniguchi Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane Carcinogenesis 14 1993 1837 1840
50. H. Iishi, M. Tatsuta, M. Baba, and H. Taniguchi Monoamine oxidase B inhibitor enhances experimental carcinogenesis in rat colon induced by azoxymethane Cancer Lett 76 1994 177 183
51. E.H. Jang, C.S. Park, and J.H. Kang Bupropion, an atypical antidepressant, induces endoplasmic reticulum stress and caspase-dependent cytotoxicity in SH-SY5Y cells Toxicology 285 2011 1 7
52. S.H. Jeon, S.H. Kim, Y. Kim, Y.S. Kim, Y. Lim, and Y.H. Lee The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells Biochem Biophys Res Commun 413 2011 311 317
53. V. Kannen, T. Marini, A. Turatti, M.C. Carvalho, M.L. Brandão, and V.A. Jabor Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats Toxicol Lett 204 2011 134 140
54. H. Karlsson, Y. Gu, J. DePierre, and L. Nässberger Induction of apoptosis in proliferating lymphocytes by tricyclic antidepressants Apoptosis 3 1998 255 260
55. P. Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease Altern Med Rev 8 2003 223 246
56. T. Kinjo, P. Kowalczyk, M. Kowalczyk, Z. Walaszek, T. Nishimaki, and T.J. Slaga Desipramine inhibits the growth of a mouse skin squamous cell carcinoma cell line and affects glucocorticoid receptor-mediated transcription Mol Carcinog 48 2009 1123 1130
57. T. Kinjo, P. Kowalczyk, M. Kowalczyk, Z. Walaszek, T.J. Slaga, and M. Hanausek Effects of desipramine on the cell cycle and apoptosis in Ca3/7 mouse skin squamous carcinoma cells Int J Mol Med 25 2010 861 867
58. M. Kirkova, E. Tzvetanova, S. Vircheva, R. Zamfirova, B. Grygier, and M. Kubera Antioxidant activity of fluoxetine: studies in mice melanoma model Cell Biochem Funct 28 2010 497 502
59. L.M. Koran, J.W. Cain, R.A. Dominguez, A.J. Rush, and S. Thiemann Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Am J Psychiatry 153 1996 1450 1454
60. C.M. Krawczyk, S. Verstovsek, P. Ujházy, D. Maccubbin, and M.J. Ehrke Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice Cancer Immunol Immunother 40 1995 347 357
61. A. Krishnan, R. Hariharan, S.A. Nair, and M.R. Pillai Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1 Biochem Pharmacol 75 2008 1924 1934
62. M. Kubera, A. Basta-Kaim, A. Skowron-Cendrzak, B. Mazur-Kolecka, A. Roman, and J. Borycz Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity Pol J Pharmacol 47 1995 321 326
63. M. Kubera, A. Simbirtsev, R. Mathison, and M. Maes Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice Psychiatry Res 96 2000 255 266
64. M. Kubera, V. Holan, R. Mathison, and M. Maes The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice Psychoneuroendocrinology 25 2000 785 797
65. M. Kubera, A.H. Lin, G. Kenis, E. Bosmans, D. van Bockstaele, and M. Maes Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J Clin Psychopharmacol 21 2001 199 206
66. M. Kubera, G. Kenis, E. Bosmans, M. Kajta, A. Basta-Kaim, and S. Scharpe Stimulatory effect of antidepressants on the production of IL-6 Int Immunopharmacol 4 2004 185 192
67. M. Kubera, A. Roman, A. Basta-Kaim, B. Budziszewska, A. Zajicova, and V. Holan Effect of acute and repeated treatment with mirtazapine on the immunity of noradrenaline transporter knockout C57BL/6J mice Pharmacol Biochem Behav 85 2006 813 819
68. M. Kubera, B. Grygier, B. Arteta, K. Urbańska, A. Basta-Kaim, and B. Budziszewska Age-dependent stimulatory effect of desipramine and fluoxetine pretreatment on metastasis formation by B16F10 melanoma in male C57BL/6 mice Pharmacol Rep 61 2009 1113 1126
69. M. Kubera, M. Maes, B. Budziszewska, A. Basta-Kaim, M. Leśkiewicz, and B. Grygier Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood Pharmacol Rep 61 2009 1105 1112
70. M. Kubera, B. Grygier, D. Wrona, Z. Rogóż, A. Roman, and A. Basta-Kaim Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice J Neuroimmunol 240-241 2011 34 44
71. C.S. Lee, Y.J. Kim, E.R. Jang, W. Kim, and S.C. Myung Fluoxetine induces apoptosis in ovarian carcinoma cell line OVCAR-3 through reactive oxygen species-dependent activation of nuclear factor-kappaB Basic Clin Pharmacol Toxicol 106 2010 446 453
72. Y. Levkovitz, I. Gil-Ad, E. Zeldich, M. Dayag, and A. Weizman Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement J Mol Neurosci 27 2005 29 42
73. C.J. Lin, F. Robert, R. Sukarieh, S. Michnick, and J. Pelletier The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling Cancer Res 70 2010 3199 3208
74. T. Lu, C.C. Huang, Y.C. Lu, K.L. Lin, S.I. Liu, and B.W. Wang Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3 Clin Exp Pharmacol Physiol 36 2009 297 303
75. S.K. Lutgendorf, and A.K. Sood Biobehavioral factors and cancer progression: physiological pathways and mechanisms Psychosom Med 73 2011 724 730
76. M. Maes, C. Song, A.H. Lin, S. Bonaccorso, G. Kenis, and R. De Jongh Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion Neuropsychopharmacology 20 1999 370 379
77. M. Maes, G. Kenis, M. Kubera, M. De Baets, H. Steinbusch, and E. Bosmans The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway Int Immunopharmacol 5 2005 609 618
78. M. Maes, Z. Fišar, M. Medina, G. Scapagnini, G. Nowak, and M. Berk New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates - Nrf2 activators and GSK-3 inhibitors Inflammopharmacology 20 2012 127 150
79. X. Mao, T. Hou, B. Cao, W. Wang, Z. Li, and S. Chen The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence Mol Pharmacol 79 2011 672 680
80. S. Merry, T.G. Hamilton, P. Flanigan, R.I. Freshney, and S.B. Kaye Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine Eur J Cancer 27 1991 31 34
81. P.G. Moorman, J.M. Grubber, R.C. Millikan, and B. Newman Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast Epidemiology 14 2003 307 314
82. P.G. Moorman, A. Berchuck, B. Calingaert, S. Halabi, and J.M. Schildkraut Antidepressant medication use and risk of ovarian cancer Obstet Gynecol 105 2005 725 730
83. K.A. Parker, S. Glaysher, J. Hurren, L.A. Knight, D. McCormick, and A. Suovouri The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures Anticancer Drugs 23 2012 65 69
84. D. Peer, Y. Dekel, D. Melikhov, and R. Margalit Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models Cancer Res 64 2004 7562 7569
85. T.C. Pellegrino, and B.M. Bayer Modulation of immune cell function following fluoxetine administration in rats Pharmacol Biochem Behav 59 1998 151 157
86. T.C. Pellegrino, and B.M. Bayer Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release Neuroimmunomodulation 8 2000 179 187
87. T.C. Pellegrino, and B.M. Bayer Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity Brain Behav Immun 16 2002 87 103
88. A. Ploppa, D.M. Ayers, T. Johannes, K.E. Unertl, and M.E. Durieux The inhibition of human neutrophil phagocytosis and oxidative burst by tricyclic antidepressants Anesth Analg 107 2008 1229 1235
89. E.W. Pommerenke, and M. Volm Reversal of doxorubicin-resistance in solid tumors by clomipramine In Vivo 9 1995 99 101
90. H. Qi, H.Z. Chen, and Z.J. Jin Caspase 3 gene expression and [Ca2 +]i homeostasis underlying desipramine-induced C6 glioma cell apoptosis Acta Pharmacol Sin 23 2002 803 807
91. H. Qi, J. Ma, Y.M. Liu, L. Yang, L. Peng, and H. Wang Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice J Neurooncol 94 2009 367 372
92. K.K. Reddy, B. Lefkove, L.B. Chen, B. Govindarajan, A. Carracedo, and G. Velasco The antidepressant sertraline downregulates Akt and has activity against melanoma cells Pigment Cell Melanoma Res 21 2008 451 456
93. A. Serafeim, M.J. Holder, G. Grafton, A. Chamba, M.T. Drayson, and Q.T. Luong Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells Blood 101 2003 3212 3219
94. C.R. Sharpe, J.P. Collet, E. Belzile, J.A. Hanley, and J.F. Boivin The effects of tricyclic antidepressants on breast cancer risk Br J Cancer 86 2002 92 97
95. J.L. Shuster, T.A. Stern, and D.B. Greenberg Pros and cons of fluoxetine for the depressed cancer patient Oncology 6 1992 45 50
96. N.D. Slamon, and V.W. Pentreath Antioxidant defense against antidepressants in C6 and 1321N1 cells Chem Biol Interact 127 2000 181 199
97. R.S. Stafford, E.A. MacDonald, and S.N. Finkelstein National patterns of medication treatment for depression Prim Care Companion J Clin Psychiatry 3 2001 232 235
98. A. Steingart, M. Cotterchio, N. Kreiger, and M. Sloan Antidepressant medication use and breast cancer risk: a case-control study Int J Epidemiol 32 2003 961 966
99. A. Stepulak, W. Rzeski, M. Sifringer, K. Brocke, A. Gratopp, and K. Kupisz Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells Cancer Biol Ther 7 2008 1685 1693
100. D. Strümper, M.E. Durieux, M.W. Hollmann, B. Tröster, C.G. den Bakker, and M.A. Marcus Effects of antidepressants on function and viability of human neutrophils Anesthesiology 98 2003 1356 1362
101. W.H. Sun, R.A. Kreisle, A.W. Phillips, and W.B. Ershler In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells Cancer Res 52 1992 5412 5415
102. M. Taler, I. Gil-Ad, L. Lomnitski, I. Korov, E. Baharav, and M. Bar Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression Eur Neuropsychopharmacol 17 2007 774 780
103. M. Taler, M. Bar, I. Korob, L. Lomnitski, E. Baharav, and N. Grunbaum-Novak Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders Int Immunopharmacol 8 2008 526 533
104. H. Tamim, J.F. Boivin, J. Hanley, M. Stang, and J.P. Collet Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants Pharmacoepidemiol Drug Saf 15 2006 689 697
105. H.M. Tamim, S. Mahmud, J.A. Hanley, J.F. Boivin, M.R. Stang, and J.P. Collet Antidepressants and risk of prostate cancer: a nested case-control study Prostate Cancer Prostatic Dis 11 2008 53 60
106. S. Toh, L.A. Rodríguez, and S. Hernández-Díaz Use of antidepressants and risk of lung cancer Cancer Causes Control 18 2007 1055 1064
107. A.J. Walker, T. Card, T.E. Bates, and K. Muir Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD Br J Cancer 104 2011 193 197
108. P.S. Wang, A.M. Walker, M.T. Tsuang, E.J. Orav, R. Levin, and J. Avorn Antidepressant use and the risk of breast cancer: a non-association J Clin Epidemiol 54 2001 728 734
109. K.J. Wernli, J.M. Hampton, A. Trentham-Dietz, and P.A. Newcomb Antidepressant medication use and breast cancer risk Pharmacoepidemiol Drug Saf 18 2009 284 290
110. Z. Xia, J.W. DePierre, and L. Nässberger Dysregulation of bcl-2, c-myc, and Fas expression during tricyclic antidepressant-induced apoptosis in human peripheral lymphocytes J Biochem Toxicol 11 1996 203 204
111. Z. Xia, J.W. DePierre, and L. Nässberger Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells Immunopharmacology 34 1996 27 37
112. Z. Xia, H. Karlsson, J.W. DePierre, and L. Nässberger Tricyclic antidepressants induce apoptosis in human T lymphocytes Int J Immunopharmacol 19 1997 645 654
113. Z. Xia, J.W. DePierre, and L. Nässberger Modulation of apoptosis induced by tricyclic antidepressants in human peripheral lymphocytes J Biochem Mol Toxicol 12 1998 115 123
114. Z. Xia, A. Bergstrand, J.W. DePierre, and L. Nässberger The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation J Biochem Mol Toxicol 13 1999 338 347
115. Z. Xia, B. Lundgren, A. Bergstrand, J.W. DePierre, and L. Nässberger Changes in the generation of reactive oxygen species and in mitochondrial membrane potential during apoptosis induced by the antidepressants imipramine, clomipramine, and citalopram and the effects on these changes by Bcl-2 and Bcl-X(L) Biochem Pharmacol 57 1999 1199 1208
116. L. Xiao, and P. Eneroth Tricyclic antidepressants inhibit human natural killer cells Toxicol Appl Pharmacol 137 1996 157 162
117. W. Xu, H. Tamim, S. Shapiro, M.R. Stang, and J.P. Collet Use of antidepressants and risk of colorectal cancer: a nested case-control study Lancet Oncol 7 2006 301 308
118. G. Ying, H. Karlsson, J.W. DePierre, and L. Nässberger Tricyclic antidepressants prevent the differentiation of monocytes into macrophage-like cells in vitro Cell Biol Toxicol 18 2002 425 437